Prolonged curarisation ill the presence of renal failure occurred in six cases where pancuranium was used, and one case where alcuranium was used. The cases are presented with a brief review of the literature..
N~O/O~, and pancuronium bromide 14 mg. Atropine 1.2 mg and neostigmine 2.5 mg did not adequately reverse her relaxation and she was left on the respirator. Three hours after the operation had finished, with her tidal volume 600 ml she was extubated but developed respiratory depression and obstruction 10 minutes later. Further neostigmine 2.5 mg and atropine 1.2 mg gave her enough strength to avoid reintubation. She was able to talk but it took a further 8 hours before she felt strong. She described her conscious paralysed state vividly. Postoperatively on the respirator her blood gases were PaO~ 7.06KPa, PaCO~ 4.99KPa, pH 7.42. Biochemistry included serum K+ 3.4 mmol/L, and normal liver function tests apart from an alkaline phosphatase of 269 I. U./L. Her serum proteins were normal.
Case 2:
A 42 year old, 61 kg lady with a lon~ history of pyelonephritis secondary to uretenc .reflu.x and ureteric calculi had been on the dIalYSIS programme for one year. She had controlled hypertension and left ventricular failure. Before transplant she underwent 3 hours haemodi~l~sis and this produced biochemistry: S. Creatlllllle 0.87 mm/L, S. Urea 13 mmol/L. Na+ 136 mmol/L, K+ 3.8 mmol/L, calcium 2.52 mmol/L, magnesium 0.8 mmol/L, prosphorus 0.92 mmol/L. Her serum proteins were normal but she had a marginally raised serum alkaline phosphatase. Premedication included azothioprine 100 mg and hydrocortisone 600 mg. The operation took 4 hours during which the fOllowing drugs were given: Pancuronium 14 mg, thiopentone 300 mg, phenoperidine 6 mg, fentanyl 100 p,g, N~O/O~, and intermittent halothane. Her blood pressure tended to be high throughout the procedure. Atropine 2.4 mg and neostigmine 4.5 mg at ~he conclusion of the operation produced inadequate reversal and eventually controlled ventilation was reinstated. Her BP was 240/120 and droperidol 10 mg, fentanyl 100 mg, and diazoxide were given. 1 t hours after the finish of the operation, while still needing respiratory support, she developed a cardiac arrest and was unable to be resuscitated.
Case 3:
A 23 year old, 48 kg woman with rheumatic heart disease had developed acute on chronic renal failure probably secondary to subacute bacterial endocarditis. She had been on the dialysis programme for 4 months when she was offered a live donor transplant. This was done and no anaesthetic difficulties were encountered. Three days later the graft was re-explored after 6 hours of haemodialysis when her serum K+ was 3.0 mmol/L. The exploration took 4t hours and anaesthetic drugs given were diazepam 15 mg, N20/0~ halothane, pancuronium 8 mg, ketamine 100 mg and fortral 15 mg. She was reversed with atropine 1.2 mg and neostigmine 2.5 mg but was not able to breathe adequately being eventually reintubated and left on ~he respirator. At this stage her K + was 4.2 mmol/L and serum proteins normal. Seven hours later she was still partially paralysed but awake. After further neostigmine she was extubated 12 hours post operatively, still weak but breathing adequately.
Case 4:
A 49 year old, 63 kg woman underwent laparotomy with repair of an umbilical hernia. She had been admitted shocked, with oliguria, (s. creatinine 0.59 mmol/L, urea 20.0 mmol/L) and it was thought that she probably had gangrene of the bowel associated with herniation. However, laparotomy was normal. The operation took 45 mins. when she was given suxamethonium 100 mg, pancuronium 6 mg, fentanyl 100 p,g. At the end she was given atropine 2.4 mg, neostigmine 4.5 mg and Allaesthesia alld IIl/eI1sil'e Care, Vol. VI, No. 3, August, 1978 naloxone 0.4 mg. She breathed initially well enough to be extubated, but had to be reintubated because of partial pamlysis. She was given suxamethonium 50 mg to facilitate reintubation and placed on the ventilator. Because of a half paralysed restless state she was given phenoperidine 2 mg and pancuronium 2 mg to settle overnight. Eight hours post operatively she showed no signs of spontaneous reversal and had a very low renal output. 14 hours post operatively, atropine 2.4 mg and neostigmine 5 mg gave her only partial reversal. At 18 hours post operatively, further atropine 1.2 mg and neostigmine 2.5 gave her a tidal volume of 600 ml and she was extubated. She remained severely oliguric but eventually recovered normal renal function.
Preoperatively, biochemistry included serum K+ 2.8 mmol/L, s. calcium 1.64 mmol/L, s. creatinine 0.59 mmol/L, pH 7.38, PaCO~ 4.39 kPa. Two hours post operatively her blood gases were PaO:! 16.7 kPa, PaCO~ 3.4 kPa, pH 7.37. Her serum K+ was 3.6 mmol/L 6 hours post operatively. Her serum proteins were normal preoperatively.
Case 5:
A 75 year old, 67 kg man underwent operation for a partial bowel obstruction due to diverticulitis. The obstruction had been present for over a week. His creatinine and urea had b~en slightly raised for some years consistent with marginal chronic renal failure. Preoperatively his biochemistry was s. urea 31 mmol/L, s. creatinine 0.51 mmol/L, K + 4.2 mmol/L, and normal liver function tests. Anaesthetic drugs included thiopentone 250 mg, suxamethonium 75 mg, N~O, atropine 0.6 mg, fentanyl 100 p,g and pancuronium 8 mg.
The operation took 2t hours. He did not reverse adequately with neostigmine 5 mg and atropine 1.2 mg, and although extubated, he had to be reintubated using suxamethonium 60 mg and valium 10 mg. Ventilation for a further 2 hours was required before a further atropine and neostigmine allowed a tidal volume adequate to sustain spontaneous respiration.
Case 6:
A 49 year old, 48 kg female underwent a 4 hour operation when a vein graft was performed to the arm. She was on the dialysis programme and had been dialysed in the previous 24 hour period. Anaesthetic drugs were cyclopropane, suxamethonium 60 mg, N~O, and pancuronium I I mg. Reversal was not adequate with atropine 1.8 mg and neostigmine 3 mg and she was returned to the respirator with diazepam for sedation. 5 hours postoperatively she was disconnected from the respirator and suffered a cardiac arrest from which she was resuscitated. She recovered consciousness but remained restless and distresse.:f. A further 30 mg of diazepam was given for sedation overnight and by 17 hours post operatively residual curarisation had disappeared and she was extubated.
Case 7:
A 24 year old, 54 kg male had an ileal conduit with a solitary right kidney. He eventually required haemodialysis and later underwent a successful renal transplant. However, 6 months after this he developed a gradual elevation of his serum creatinine an.:! the diagnosis of partial obstruction was made. He underwent a 4 hour operation when a stenotic area of the ureteric implant was refashioned, Preoperative biochemistry was s. creatinine 0.49 mmol/ L, s. urea 19.0 mmol/L. Na+ 135 mmol/L, K+ 4.9 mmol/L, calcium 1.94 mmol/L. Liver function tests normal. Anaesthetic drugs included fentanyl 750 {Lg, aIcuronium 42 mg, thiopentone 300, N~O /O~. Reversal with atropine 1.2 mg and neostigmine 2.5 mg allowed extubation but he was unable to breath adequately, and was reintubated half an hour later. Phenoperidine was used for sedation. 24 hours later he was conscious and co-operative and had a tidal volume of 500 ml. After extubation he had to be reintubated because he was unable to maintain muscle power. He was eventually extubated 48 hours post operatively and subsequently described the typical sensations of paralysis while being conscious.
DISCUSSION
It is generally accepted that gallamine must be avoided in renal failure patients (Feldman 1973, Churchill-Davidson, Way and deJong 1967) . Some have been prepared to use it in small doses (White, De Weerd and Dawson 1971 ) . However most present day techniques where muscle relaxation is required use either d-tubocurarine or pancuronium.
Tubocurarine has been declare.:i safe in a number of series (Churchill-Davidson, Way and deJong 1967, Monks and Lumley 1972, Samuel and Powell 1970) . However isolated reports have been emerging showing that occasional cases do not reverse well. (Rouse, G alley and Bevan 1977 , Riordan and Gilbertson 1976 , Katz, Kountz and Cohn 1967 . Evidence for instances of recurarisation is convincing (Miller and Cull en 1976) .
Pancuronium is now being used widely mainly because it causes less hypotensio'1. Again early reports suggested pancuronium was safe to use (Kamvyssi-Dea, Papadimitrioui and Dousaitou J 972, Slawson 1972 ). There are now several reports of difficulty in reversal or recurarisation following its use in renal failure patients (Miller and Cullen 1976 , Rouse. Galley and Bevan 1977 , Abrams and Hornbein 1975 . We add our six cases to those already reported.
AIcuronium seems to be rarely used and we have not seen a report of it causing persistent muscle relaxation in renal failure.
Factors which may be concerned in cases of neostigmine resistant curarisation include biochemical factors, "sensitivity" to relaxant drugs, and pharmacokinetics of the drugs.
BIOCHEMICAL FACTORS
Those which may be concerned include acid base status (Norman, Katz and Seed 1970) , serum potassium (Feldman 1973) , and serum proteins (Stovner, Theodorsen and Bjelke 1972) . In our patients these factors were not significantly abnormal except perhaps case 4 where the preoperative potassium was 2.8 mmol/L. However she was still weak with a K-i level of 3.6 mmol/L, 6 hours post operatively. (Case 6 did not have a recorded level. ) "SENSITIVITY" TO RELAXANT DRUGS Most anaesthetists who use pancuronium have had the occasional patient of normal biochemical and renal status who does not reverse well with neostigmine. Usually this is due to large or recent dosage. Hunter (1976) speaks of this problem and says he is aware of 2 cases of recurarisation after pancuronium which he puts down to liberal use of the drug. However occasionally a patient is difficult to reverse after normal dosage and it is the clinical experience of two of the authors of this paper that reversal problems with pancuronium are not uncommon after routine anaesthesia. Some patients for as yet unknown reasons seem abnormally sensitive to pancuronium. It may not be irrelevant to this clinical experience that difficulty in recovery after pancuronium is AII"e,\{he.~i(l Will /111(;,1I.\i\'(;' C(lre. I/o/. VI, No, 3, Allgll,\ (, 197H starting to be reported in renal failure patients more frequently than tubocurarine has in the past, even though large numbers of renal transplants have been done using the latter drug.
PHARMACOKINETICS
The pharmacokinetics of d-tubocurarine have been partly elucidated. It is largely excreted in the urine. However, in dogs and probably humans there seems to be an alternative route via the biliary tree (Cohen, Brewer and Smith 1967) . Using computer simulations, Gibaldi, Levy and Hay ton (1972) predicted that the absence of renal function will have little effect on the duration of relatively small single doses of tubocurarine but that the duration of action of large single doses and multiple doses will be prolonged significantly.
The fate of pancuronium is probably similar to tubocurarine though again there is a surprising dearth of definite information in humans. The plasma concentration declines biexponentially. The initial fast phase due to redistribution is followed by a slower elimination phase which is due to excretion via the kidney, biliary tree, and some metabolism (Speirs and Sim 1972, Strunin, Strunin and Lay ton 1972) . The proportion of pancuronium excreted by kidney and liver in normal man are unknown. Agoston, Kersten and Meijer (1973) found that cats excreted 30% of pancuronium in the urine and the rest was excreted or metabolised by the liver. Although the elimination has been poorly elucidated in humans, there is no doubt that plasma pancuronium concentrations decline more slowly in patients with severe renal failure (McLeod, Watson and Rawlins 1975) . Furthermore it has been shown that in patients with renal failure sufficient to require renal transplantation 1.8-5.5 mg of pancuronium produce a neuromuscular blockade lasting 20-40 minutes longer than that produced in patients with normal renal function (Miller, Stevens and Way 1973) . It would seem reasonable to extrapolate the computer simulations of Gibaldi, Levy and Hay ton (1972) from d-tubocurarine to pancuronium. The intra-anaesthetic doses of pancuronium in our cases were 14 mg, 14 mg, 8 mg, 6 mg, 11 mg and 8 mg respectively. The two doses of 14 mg are rather large though the operations were long and increments were given only when the patient started to move or increased muscle relaxation seemed clinically indicated. It is possible that increased narcotic Anaesthesia and Intensive Care. Vol. VI. No, 3, August, 1978 or inhalational drug dose may have avoided the need for extra relaxant.
Alcuronium (diallyl nor toxifernine dichloride) does not seem to appear in the literature as a cause of prolonged relaxation in renal failure. There is no evidence of appreciable metabolism of the drug in the body of animals and most of the injected radioactive labelled drug is excreted unchanged in the urine. There is no experimental evidence of an alternative pathway of excretion as there is for curare (Feldman 1973) . Thus it is probably contra-indicated in renal failure, Our case was one where the transplanted kidney was functioning but with a raised serum creatinine. The patient needed 48 hours on the respirator before adequate reversal was achieved.
Recurarisation has been reported in renal failure patients (Miller and Cullen 1976) . It is quite common for residually paralysed patients to be extubated for a period before having to be re-intubated. One is never quite sure whether recurarisation is involved or the patient is merely decompensating to the position where observers finally realise what is happening. However given the pharmacokinetics of neostigmine it would seem inevitable that as it is eliminated from the body in the presence of persisting high levels of relaxant that recurarisation must occur. Miller and Cullen (1976) suggest pyridostigmine may be safer because it has a slower excretion rate. CONCLUSION 
Present knowledge
of the pharmacokinetics of pancuronium and clinical reports of reversal problems in patients with renal failure suggests that it must be used with caution. Tubocurarine has been used without apparent incident in some large series -this suggests that it will produce less neostigmine resistant reversal problems than pancuronium. Alcuronium is probably contraindicated in patients with renal failure.
